Generic Drugs Pricing Antitrust
In Re: Generic Pharmaceuticals Pricing Antitrust Litigation, MDL No. 2724 (E.D. Pa.).
Lieff Cabraser represents AFCSME DC 37, a municipal union health and welfare fund headquartered in New York City, and other health and welfare funds covering tens of thousands of individuals in litigation alleging that various drug companies conspired to keep producers of generic versions of numerous drugs from competing against each other.
Beginning in February 2015, Lieff Cabraser conducted an extensive investigation into dramatic price increases of certain generic drugs. Lieff Cabraser worked alongside economists and industry experts and interviewed industry participants to evaluate possible misconduct. In December of 2016, Lieff Cabraser, with co-counsel, filed the first case alleging price-fixing of levothyroxine, the primary treatment for hypothyroidism, among the most widely prescribed drugs in the world.
Lieff Cabraser also played a significant role in similar litigation over the drug propranolol in the Southern District of New York. On May 19, 2017, Lieff Cabraser partner Elizabeth Cabraser was named to the End-Payer Plaintiffs’ Plaintiff Steering Committee.
Related generic drug price-fixing cases were consolidated into a Multi-District Litigation before the Honorable Cynthia M. Rufe in the Eastern District of Pennsylvania in 2016. Judge Rufe has since denied multiple rounds of motions to dismiss, and has allowed the plaintiffs’ allegations of an industry-wide “overarching conspiracy” to fix drug prices to proceed. Substantial discovery has already taken place, and the litigation is ongoing.
Civil Litigation News
Lieff Cabraser Announces Historic $235M Comprehensive Settlement with Altria in National JUUL Youth E-Cigarette Predatory Advertising, Addiction and Injury Cases
Unprecedented in scope, speed, and significance, the global settlement, reached just after plaintiffs concluded their case in the bellwether trial in San
Avery Halfon Named to Law360’s 2023 Consumer Protection Editorial Advisory Board
Law360 has selected Lieff Cabraser attorney Avery Halfon to serve as one of the lawyers on its 2023 Consumer Protection Editorial Advisory board.
Ex-JUUL COO Claims He Was Fired For Sharing Concerns About JUUL Targeting Teen Users
As reported by Law360 in its ongoing coverage of the JUUL multidistrict injury and predatory/fraudulent advertising litigation against Altria (formerly Philip Morris), extraordinary